产品描述信息
NR-667?? Polyclonal Anti-Influenza Virus N9 Neuraminidase (NA), A/tern/Australia/G70C/1975 (H11N9), (antiserum, Goat)(Polyclonal Antiserum)|Influenza A virus|Polyclonal Anti-Influenza Virus N9 Neuraminidase (NA), A/tern/Australia/G70C/1975 (H11N9), (antiserum, Goat)|-20°C to -40°C|NIH - Influenza Pandemic Preparedness in Asia ProgramAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Polyclonal Anti-Influenza Virus N9 Neuraminidase (NA), A/tern/Australia/G70C/1975 (H11N9), (antiserum, Goat), NR-667."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.Antiserum to the N9 neuraminidase (NA) from influenza virus A/tern/Australia/G70C/1975 (H11N9) was produced by immunization of goat with the recombinant protein. NR-667 is specific to the N9 NA subtype of influenza virus as determined in serological neuraminidase inhibition (NI) assays. NR-667 demonstrates broad reactivity within the N9 NA subtype, including both North American and Eurasian N9 NA isolates, based on NI and ELISA assays.Each vial contains lyophilized (0.5 mL) goat polyclonal antiserum to the N9 NA from influenza virus A/tern/Australia/G70C/1975 (H11N9). Note: The strain designation on the vials is incorrect. The vials should be labeled influenza virus, A/tern/Australia/G70C/1975 (H11N9) rather than A/tern/Australia/G70C/75 (H1N9).NR-667 should be reconstituted with 0.5 mL of sterile distilled water. Note: Reconstitution with PBS (per the vial label) will result in excess salt.